Biohaven Pharma

BHVN NYSE
45.25
+1.15
+2.61%
盘后: 45.25 0 0.00% 16:30 07/22 EDT
开盘
43.10
昨收
44.10
最高
45.30
最低
42.72
成交量
110.00万
成交均量(3M)
100.52万
52周最高
67.86
52周最低
29.17
换手率
2.12%
市值
23.43亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Biohaven Pharma BHVN股票价格,Biohaven Pharma股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Biohaven Pharmaceutical Holding Company Ltd. is a biopharmaceutical company. The Company is engaged in the identification and development of clinical-stage compounds targeting orphan neurologic indications and other neurological pathways. The Company's glutamate platform includes three clinical-stage product candidates being developed for the treatment of various neurological indications: trigriluzole for the treatment of obsessive-compulsive disorder (OCD), spinocerebellar ataxia (SCA) and Alzheimer's disease; BHV-0223 for the treatment of amyotrophic lateral sclerosis (ALS), and BHV-5000 for the treatment of neurological and psychiatric illnesses such as Rett syndrome, neuropathic pain and treatment-resistant depression. BHV-0223 is developing for the treatment of ALS, a neurodegenerative disease that affects nerve cells in the brain and spinal cord.
展开 >

最近浏览

名称
价格
涨跌幅